About MitoSciences
MitoSciences is a Healthcare company based in Eugene (United States) founded in 2004, and was acquired by Abcam in May 2011. Mitochondrial antibodies, assays, and toxicity screening products are provided. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
MitoSciences was established in 2004 in Eugene, United States, within the biotechnology sector focused on mitochondrial research. Monoclonal antibodies and immunoassays are developed to evaluate drug and disease effects on mitochondrial and metabolic functions. Contract research services are offered to support these assessments. Since May 2011, the company has been operated as a subsidiary of Abcam, with activities centered on specialized assays and screening tools.
- Headquarters Eugene, United States
- Stage Acquired
- SectorsHealthcare
- Website mitosciences.com
- Social LinkedIn
- Acquired by Abcam (May 2011)
Funding Insights of MitoSciences
- Total Rounds 5
- Last Round Grant β $244,000
- First Round $591,470
(Jul 2004)
- Investors Count 4
All 5 funding rounds of MitoSciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
5 investors in total: 5 institutional.
Investors in MitoSciences
MitoSciences has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include Abcam, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tax administration and collection services by the US government. | irs.gov | |||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Provider of event management services | 1991 | oen.org | Portland, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Biological reagents and antibodies are developed for life science research. | 1998 | abcam.com | Cambridge, United Kingdom |
Investor details for MitoSciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MitoSciences
4 dated milestones of MitoSciences across 7 years, from founding to its latest funding, stage changes and deals.
- Founded MitoSciences is founded.
- Funding First funding round of $591K.
- Funding Latest funding round, Grant, of $244K.
- Exit Acquired by Abcam.
Competitors of MitoSciences
MitoSciences has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of MitoSciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MitoSciences
Websites that share an audience with MitoSciences (mitosciences.com).
Websites whose visitors overlap most with MitoSciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| randox-lifesciences.com | 100% | View details | |||
| abnova.com | 100% | 30.7K | #957,320 | View details | |
| prospecbio.com | 91% | 53.2K | #651,600 | View details | |
| epitomics.com | 88% | View details | |||
| invitrogen.com | 88% | 5.2K | #3,688,642 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 27 similar websites and full traffic analytics for MitoSciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as MitoSciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MitoSciences
MitoSciences was founded in 2004.
MitoSciences is headquartered in Eugene, United States. It is registered at Eugene, Oregon, United States.
MitoSciences was established in 2004 in Eugene, United States, within the biotechnology sector focused on mitochondrial research. Monoclonal antibodies and immunoassays are developed to evaluate drug and disease effects on mitochondrial and metabolic functions. Contract research services are offered to support these assessments. Since May 2011, the company has been operated as a subsidiary of Abcam, with activities centered on specialized assays and screening tools.
MitoSciences's top competitors include GenScript, Epitomics and Vector Laboratories.
MitoSciences has 5 investors. Key investors include Abcam, NIH, HHS, OEN, and Internal Revenue Service.
Yes. MitoSciences was acquired by Abcam in May 2011.
